Gilead Sciences can now start going to work on commercializing the drug it paid $11 billion to get a couple years ago.
The Foster City, CA-based biotech company (NASDAQ: GILD) said today it has gotten FDA clearance to start selling... Read more »
The startup spotlight in Austin has long focused on the city’s techie scene of software startups, app developers, and the like, but a medtech community has been developing, too. And Dennis McWilliams, who currently runs Apollo Endosurgery, has been along for... Read more »
Cubist Pharmaceuticals may have added some punch to its antibiotics portfolio by buying Optimer Pharmaceuticals a few months ago, but as is often the case with M&A deals, the buyout is also precipitating a lot of job cuts.
The Jersey Journal... Read more »
Rally Software’s roll continued this week, with the company’s latest quarterly revenue beating expectations while CEO Tim Miller earned an award for being Colorado’s top CEO.
The Boulder-based software development company (NYSE: RALY) announced late Thursday a 28 percent year-to-year... Read more »
The holidays are in full swing, as are some big startup ideas that have had the biotech world buzzing over the past few weeks. Those stories and more as the roundup returns from a Thanksgiving break:
—Juno Therapeutics earned the distinction... Read more »
Wait, what? Cyber Monday was four days ago, and you still haven’t finished your holiday gift buying?
Don’t worry, we haven’t either. But we thought we’d take some time away from our busy shopping schedules to help you find the best... Read more »
Rust never sleeps, and neither does the news. Here’s my wrap-up of the latest developments from San Diego’s life sciences community.
—San Diego-based Ignyta, which trades over the counter under the ticker symbol RXDX, said it has raised a total... Read more »
The Detroit-based startup H2bid.com—an e-bidding site that maintains, according to the company, the world’s largest online clearinghouse of water utility contract opportunities—recently made some waves in Silicon Valley.
Company founder and CEO Glenn Oliver says H2bid was invited to be part... Read more »
In just 10 years, Tesla Motors has become a symbol of automotive excellence and an iconic company for risk-taking and determined entrepreneurs everywhere. But according to director and early investor Ira Ehrenpreis, it wasn’t always that way.
Ehrenpreis is a general... Read more »